Amphastar pharmaceuticals completes acquisition of baqsimi from lilly

Rancho cucamonga, ca / accesswire / june 30, 2023 / amphastar pharmaceuticals, inc. (nasdaq:amph) ("amphastar" or the "company") today announced that it has completed the previously announced acquisition of baqsimi® from eli lilly and company ("lilly") (the "acquisition"). acquisition highlights provides amphastar with a branded product with growing sales and strong gross margin.
AMPH Ratings Summary
AMPH Quant Ranking